T. Pertseva (Dnepropetrovsk, Ukraine), P. Ind (East Acton, United Kingdom)
In vitro comparison of Pulmicort Respules™ with Clenil® pro aerosol in combination with three nebulisers
A. Vaghi, E. Berg, S. Liljedahl, J. O. Svensson (Garbagnate, Italy; Lund, Sweden)
|  |
The ATACO study: adjustable maintenance therapy with budesonide and formoterol in a single inhaler
P. Kardos, B. Brueggenjuergen, A. Baare, W. Meyer-Sabellek, K. Richter, C. Vogelmeier, S. N. Willich, R. Buhl (Frankfurt, Berlin, Wedel, Grosshansdorf, Marburg, Mainz, Germany)
| |
4-month adjustable or fixed maintenance treatment with budesonide/formoterol in a single inhaler reduces symptom severity
P. Ind, J. Haughney, D. Price, J. P. Rosen, J. Kennelly (London, Luton, United Kingdom)
| |
Adjustable maintenance treatment with budesonide/formoterol combination rapidly improves and maintains quality of life in asthma patients
J. Haughney, D. Price, J. P. Rosen, J. Kennelly (Aberdeen, Luton, United Kingdom)
| |
Managed adjustable dosing of budesonide/formoterol combination is similarly well tolerated to fixed dosing
P. Ind, J. Haughney, J. P. Rosen, J. Kennelly (London, Aberdeen, Luton, United Kingdom)
| |
Inhalation of beclomethason dipropionate spray compared with theophilline as primary treatment for chronic mild-to-moderate asthma
M. I. Boskovska, C. A. Busletic, Z. D. Goseva, Z. S. Arsovski (Skopje, Macedonia)
| |
Comparison of medium dose inhaled beclomethasone dipropionate (BDP) and low dose inhaled BDP plus sustained-release theophylline in the treatment of patients with moderate persistent asthma
O. B. Dimitrijevic, M. D. Filipovic, S. S. Cekic (Nis, Yugoslavia)
| |
Efficacy and safety of long-term therapy with Salamol combined with Beclason versus Salamol only in patients with mild persistent asthma
K. E. Bogatska, T. O. Pertzeva, K. Y. Gashynova (Dnepropetrovsk, Ukraine)
| |
Considerations about cost-effectiveness and global satisfaction of asthmatic patients treated with montelukast compared with inhaled corticosteroids
P. Leru, C. Baicus, D. Gologanu (Bucharest, Romania)
| |
Health care costs associated with acute asthma: a economic analysis
L. A. Santos, M. A. Oliveira, S. M. Faresin, A. Barbieri, A. L. G. Fernandes (São Paulo, Brazil)
| |
Cost-effectiveness of early intervention with budesonide once daily: Results from the START study
S. D. Sullivan, M. Buxton, L. F. Andersson, C. J. Lamm, B. Liljas, Y. Z. Chen, R. A. Pauwels, K. B. Weiss (Seattle, Chicago, United States Of America; Uxbridge, United Kingdom; Lund, Sweden; Beijing, China; Gent, Belgium)
| |
The cost-effectiveness of early intervention with inhaled budesonide once daily: an international comparison of the results from the START study
M. Buxton, S. D. Sullivan, L. F. Andersson, C. J. Lamm, B. Liljas, W. W. Busse, S. Pedersen, K. B. Weiss (Uxbridge, United Kingdom; Seattle, Madison, Chicago, United States Of America; Lund, Sweden; Kolding, Denmark)
| |
Efficacy, safety and cost of budesonide/formoterol in a single inhaler compared with budesonide plus formoterol as separate inhalers
L. Rosenhall, A. Elvstrand, B. Tilling, I. Vinge, P. Jemsby, E. Ståhl, F. Jerre, K. Ericsson, S. Borg, T. Callréus, P. B. F. Bergqvist (Stockholm, Kil, Åtvidaberg, Lidingö, Varberg, Lund, Sweden)
| |
Cost-effectiveness of formoterol turbuhaler versus salbutamol as reliever therapy in asthma: results from the RELIEF worldwide randomised effectiveness study
| |
Total costs according to reliever use of formoterol turbuhaler in asthma: results from the RELIEF worldwide randomized effectiveness study, stratified by maintenance medication levels
| |
Formoterol turbuhaler compared with salbutamol as reliever medication in asthma: a worldwide, randomised, effectiveness trial (RELIEF Study)
| |
Formoterol turbuhaler compared with salbutamol as reliever medication in asthma: an exploratory analysis of the RELIEF study in patients using formoterol as maintenance therapy
| |
Safety of formoterol turbuhaler when used as a reliever therapy in asthma (the RELIEF study)
| |
Safety of formoterol turbuhaler used as reliever in asthma: relationship with age and baseline treatment including regular long-acting β2-agonists (the RELIEF study)
| |
Formoterol turbuhaler compared with salbutamol as reliever medication in asthma: outcomes from the RELIEF study in patients across different severities and age groups
| |